Multi drug resistant cancer is associated with loss of TP53TG1 molecule

A new study by researchers at the Bellvitge Biomedical Research Institute (IDIBELL) has found a cause of multiple resistance in cancer chemotherapy. They discovered that 10% of colon and stomach tumors present wit loss of a molecule called TP53TG1. The functionof TP53TG1 is to prevent activation of YBX1 protein. Without surveillance of TP53TG1 in these… Continue reading Multi drug resistant cancer is associated with loss of TP53TG1 molecule